This thesis focuses on the non-motor symptoms (NMS) of Parkinson's disease (PD), with particular emphasis on impulsive-compulsive spectrum behaviours (ICBs). The relevance of NMS is investigated as presenting complaints amongst 21% of 433 patients with pathologically-proven PD. These patients had delayed diagnosis of PD, and often underwent unnecessary and potentially harmful interventions. Motor and NMS of LRRK2- associated PD are compared with idiopathic PD, and NMS of LRRK2-associated PD are more benign than in idiopathic PD. Increased Lewy body burden was shown to correlate with NMS in a subgroup of idiopathic PD patients at post-mortem. A metanalysis investigates pathological gambling and the dopamine dysregulation syndrome in PD, hi...
Changes in reward circuitry have been studied extensively in substance and behavioural addictions. H...
Throughout the past decade it has been recognized that dopaminergic medication administered to remed...
Dopaminergic medications used in the treatment of patients with Parkinson's disease are associated w...
There is an increasing awareness that impulse control disorders (ICDs), including compulsive gamblin...
The phenomenology of impulsive compulsive behaviours in patients with Parkinson’s disease (PD) treat...
Pathological gambling (PG) and other Impulse Control Disorders (ICDs), such as hypersexuality, compu...
The current study aimed at establishing the prevalence of impulse control disorders (ICDs) in patien...
ABSTRACT Neuropsychiatric disorders are common among patients with Parkinson’s disease and may appea...
Over the last decade, evidence has emerged linking disorders in the impulsive-compulsive spectrum in...
Dopamine is an essential neurotransmitter for many brain functions, and its dysfunction has been imp...
In a small number of patients with Parkinson’s disease (PD), a series of behavioral disorders includ...
Background: “Impulse Control Disorders” are behavioral conditions (e.g., gambling, hypersexuality), ...
Non-motor symptoms contribute significantly to Parkinson’s disease (PD) related disability. Impulse ...
Thesis (Ph.D.)--University of Rochester. School of Medicine & Dentistry. Dept. of Neurobiology and A...
Impulse control disorders (ICD) in Parkinson’s dis-ease (PD) are a disabling non-motor symptom with ...
Changes in reward circuitry have been studied extensively in substance and behavioural addictions. H...
Throughout the past decade it has been recognized that dopaminergic medication administered to remed...
Dopaminergic medications used in the treatment of patients with Parkinson's disease are associated w...
There is an increasing awareness that impulse control disorders (ICDs), including compulsive gamblin...
The phenomenology of impulsive compulsive behaviours in patients with Parkinson’s disease (PD) treat...
Pathological gambling (PG) and other Impulse Control Disorders (ICDs), such as hypersexuality, compu...
The current study aimed at establishing the prevalence of impulse control disorders (ICDs) in patien...
ABSTRACT Neuropsychiatric disorders are common among patients with Parkinson’s disease and may appea...
Over the last decade, evidence has emerged linking disorders in the impulsive-compulsive spectrum in...
Dopamine is an essential neurotransmitter for many brain functions, and its dysfunction has been imp...
In a small number of patients with Parkinson’s disease (PD), a series of behavioral disorders includ...
Background: “Impulse Control Disorders” are behavioral conditions (e.g., gambling, hypersexuality), ...
Non-motor symptoms contribute significantly to Parkinson’s disease (PD) related disability. Impulse ...
Thesis (Ph.D.)--University of Rochester. School of Medicine & Dentistry. Dept. of Neurobiology and A...
Impulse control disorders (ICD) in Parkinson’s dis-ease (PD) are a disabling non-motor symptom with ...
Changes in reward circuitry have been studied extensively in substance and behavioural addictions. H...
Throughout the past decade it has been recognized that dopaminergic medication administered to remed...
Dopaminergic medications used in the treatment of patients with Parkinson's disease are associated w...